Loss of OSM function in vivo is associated with a decrease in the level of several inflammatory signals with known pro-tumorigenic function, a shift in the myeloid to MØ infiltration of orthotopic tumours, as well as improved function of APCs and T cells. The gene discussed is OSM; the disease is neoplasm.